CBD has shown promise for several genetic epilepsies, but specific evidence for CDKL5 Deficiency Disorder remains limited and largely anecdotal.
Pediatric neurologists, CDD families, and epilepsy trial researchers.
CBD approved for 3 genetic epilepsies, but zero trial data for CDKL5 Deficiency Disorder
What the researchers found
CBD is proven for LGS, Dravet, and TSC. For CDD, evidence relies on anecdotal reports using artisanal products with unknown compositions. Preclinical models could help establish efficacy.
Why it matters
CDD causes devastating seizures that existing drugs often fail to control. Establishing whether cannabinoids work through CDD-specific pathways could justify targeted trials.
The numbers in context
CDD seizures can exceed 10 daily in severe cases. CBD approved for 3 genetic epilepsies. No clinical trial data for CDD.
How the study worked
Narrative review examining clinical trials and preclinical models of cannabinoids in genetic epilepsies, with focus on CDD.
What this study cannot tell us
No CDD trial data. Anecdotal reports use unknown compositions. Molecular overlap with other epilepsies is theoretical.
How to read the evidence
Review relying on extrapolation from other conditions and anecdotal CDD reports.
When this study was published
Published in 2024.
The bigger picture
Off-label cannabinoid use is already happening in CDD without adequate evidence. The approved indication list may need to expand.
Questions still open
- Do cannabinoids interact with CDD-specific molecular pathways?
- Should CDD be prioritized for CBD clinical trials?
Common questions
Can CBD help CDKL5 Deficiency Disorder?
Why isn't CBD approved for all genetic epilepsies?
Read the original research
Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder.
International journal of molecular sciences, 25(19)
Citation
Massey, Sean; Quigley, Anita; Rochfort, Simone; Christodoulou, John; Van Bergen, Nicole J. (2024). Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder.. International journal of molecular sciences, 25(19). https://doi.org/10.3390/ijms251910768
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk